ABVC BioPharma, Inc. (ABVC) Tops Q3 EPS by 38c

ABVC BioPharma, Inc. (NASDAQ: ABVC) reported Q3 EPS of ($0.02), $0.38 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $380 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on ABVC BioPharma, Inc. (ABVC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Ticketplus files for IPO with shares priced between $13-$15
• PreveCeutical closes second tranche of private placement for $245,000